Double-vessel verylate stent thrombosis following Resolute Onyx zotarolimus eluting stents implantation in an octogenarian  

作　　者：George Kassimis Tushar Raina 

机构地区：[1]Department of Cardiology,Cheltenham General Hospital,Gloucestershire Hospitals NHS Foundation Trust,Cheltenham,United Kingdom [2]Second Department of Cardiology,Hippokration Hospital,Medieal School,Aristotle University of Thessaloniki,Thessaloniki,Greece

出　　处：《Journal of Geriatric Cardiology》2018年第10期639-643,共5页老年心脏病学杂志（英文版）

摘　　要：Compared with bare-metal stents (BMS),drug-eluting stems (DES)have shown better clinical outcomes for pa- tients undergoing percutaneous coronary intervention (PCI) by inhibition of neo-intirnal hyperplasia.[1]However,early- generation DES produced late thrombotic events,more than l-year,by delaying arterial healing of stented vessels,[2-5] New-generation DES have been developed'with thinner stent struts,more biocompatible polymer coatings for drug release,and a variety of antiproliferative agents with similar or superior anti-restenotic efficacy.[6]This development has led to a significant improvement in the efficacy and safety of new-generation DES,and consistently lower rates of very late stent thrombosis (VLST).[7,8]In fact,use of new-ge- neration DES is the standard treatment in contemporary PCI practice.[9]

关 键 词：DOUBLE VESSEL occlusion Myocardial infarction Very late stent thrombosis ZOTAROLIMUS eluting STENTS 

分 类 号：R[医药卫生]